Pacgen Biopharmaceuticals Corporation   Report issue

For profit Phase 2
Founded: Vancouver BC Canada (2004)
Status: Left NME R&D (2018)

Organization Overview

First Clinical Trial
2008
NCT00659971
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now